Skip to main content
SpringerLink
Log in

Inhalants Abuse: Status of Etiology and Intervention

  • Chapter
  • First Online:
Drug Abuse and Addiction in Medical Illness

  • 4542 Accesses

Abstract

Inhalants differ from other psychoactive substances in that thousands of commercial ­products can produce intoxication and toxicity if inhaled, they are widely available, legal, inexpensive, and easily obtained. Moreover, relatively few parents, retailers, school personnel, law enforcement professionals, or human services workers are vigilant about inhalant use or inhalant-related health and social problems. Numerous medical, cognitive, emotional, and social consequences and correlates of inhalant use have been documented including abuse and dependence. Moreover, little research has tested prevention or treatment programs specifically for inhalant abuse. This chapter summarizes extant research on etiology and clinical practices pertaining to inhalant use and abuse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Howard MO, Walker RD, Walker PS, Cottler LB, Compton WM. Inhalant use among urban American Indian youth. Addiction. 1999;94:83–95.

    PubMed  CAS  Google Scholar 

  2. Howard MO, Balster RL, Cottler LB, Wu LT, Vaughn MG. Inhalant use among incarcerated adolescents in the United States. Drug Alcohol Depend. 2008;93:197–209.

    PubMed  Google Scholar 

  3. Ridenour TA. Inhalants: not to be taken lightly anymore. Curr Opin Psychiatry. 2005;18:243–7.

    PubMed  Google Scholar 

  4. SAMHSA. Characteristics of recent adolescent inhalant initiates (issue 11). Washington, DC: Office of Applied Studies; 2006. p. 1–4.

    Google Scholar 

  5. National Institute on Drug Abuse. Inhalant abuse. Washington, DC: NIH; 2000. Pub No 00-3818.

    Google Scholar 

  6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  7. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend. 1998;51:207–14.

    PubMed  CAS  Google Scholar 

  8. Bowen SE, Batis JC, Paez-Martinez N, Cruz SL. The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol. 2006;28:636–47.

    PubMed  CAS  Google Scholar 

  9. Lubman DI, Yucel M, Lawrence AJ. Inhalant abuse among ­adolescents: neurobiological considerations. Br J Pharmacol. 2008;154:316–26.

    PubMed  CAS  Google Scholar 

  10. Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ. Inhaled drugs of abuse enhance serotonin-3-receptor function. Drug Alcohol Depend. 2003;70:11–5.

    PubMed  CAS  Google Scholar 

  11. Paez-Martinez N, Cruz SL, Lopez-Rubalcava C. Comparative study of the effects of toluene, benzene, 1,1,1-trichloroethane, diethyl ether, and flurothyl on anxiety and nociception in mice. Toxicol Appl Pharmacol. 2003;193:9–16.

    PubMed  Google Scholar 

  12. Kurbatt RS, Pollack CV. Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med. 1998;16:167–9.

    Google Scholar 

  13. Cox MJ. Severe burn injury from recreational gasoline use. Am J Emerg Med. 1996;14:39–42.

    PubMed  CAS  Google Scholar 

  14. Moreno C, Beierle EA. Hydrofluoric acid burn in a child from a compressed air duster. J Burn Care Res. 2007;28:909–12.

    PubMed  Google Scholar 

  15. Foster KN, Jones L, Caruso DM. Hydrofluoric acid burns resulting from ignition of gas from a compressed air duster. J Burn Care Rehabil. 2003;24:234–7.

    PubMed  Google Scholar 

  16. Keriotis AA, Upadhyaya HP. Inhalant dependence and withdrawal symptoms. J Am Acad Child Adolesc Psychiatry. 2000;39:679–80.

    PubMed  CAS  Google Scholar 

  17. Jung I, Lee HJ, Cho BH. Persistent psychotic disorder in an ­adolescent with a past history of butane gas dependence. Eur Psychiatry. 2004;19:519–20.

    PubMed  Google Scholar 

  18. Avella J, Wilson JC, Lehrer M. Fatal cardiac arrhythmia after repeated exposure to 1,1-difluoroethane. Am J Forensic Med Pathol. 2006;27:58–60.

    PubMed  Google Scholar 

  19. Bowen CE, Daniel J, Balster RL. Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend. 1999;53:239–45.

    PubMed  CAS  Google Scholar 

  20. Esmail A, Warburton B, Bland JM, Anderson HR, Ramsey J. Regional variations in deaths from volatile solvent abuse in Great Britain. Addiction. 1977;92:1765–71.

    Google Scholar 

  21. Esmail A, Anderson JD, Ramsey JD, Taylor J, Pottier A. Controlling deaths from volatile substance use in under 18s: the effects of legislation. Br Med J. 1992;305:692.

    CAS  Google Scholar 

  22. Johns A. Volatile solvent use and 963 deaths. Br J Addict. 1991;86:1053–6.

    PubMed  CAS  Google Scholar 

  23. Yamanouchi OS, Kodama K, Sakamoto T, Sekine H, Hirai S, Murkami A, Komatsu N, Sato T. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand. 1997;96:34–9.

    PubMed  CAS  Google Scholar 

  24. Tenbein M, Pillay N. Sensory evoked potential in inhalant (volatile solvent) abuse. J Paediatr Child Health. 1993;29:206–8.

    Google Scholar 

  25. Sharp CW, Rosenberg N. Inhalant-related disorders. In: Tasman A, Kay J, Lieberman JA, editors. Psychiatry, vol. 1. Philadelphia: Saunders; 1997.

    Google Scholar 

  26. Sharp CW, Rosenberg N. Inhalants. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Substance abuse: a comprehensive textbook. Baltimore: Williams & Wilkins; 1997.

    Google Scholar 

  27. Hoek JAF, Verberk MM, Hageman G. Criteria for solvent-induced chronic toxic encephalopathy: a systematic review. Int Arch Occup Environ Health. 2000;73:362–8.

    PubMed  Google Scholar 

  28. Mikkelsen S. Epidemiological update on solvent neurotoxicity. Environ Res. 1997;73:101–12.

    PubMed  CAS  Google Scholar 

  29. Soderkvist P, Ahnadi A, Akerback A, Axelson O, Flodin U. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scand J Work Environ Health. 1996;22:360–3.

    PubMed  CAS  Google Scholar 

  30. Morrow LA, Stein L, Bagovich GR, Condray R. Neuropsychological assessment, depression, and past exposure to organic solvents. Appl Neuropsychol. 2001;8:65–73.

    PubMed  CAS  Google Scholar 

  31. Morrow LA, Steinhauer SR, Condray R, Hodgson M. Neuropsychological performance of journeyman painters under acute solvent exposure and exposure-free conditions. J Int Neuropsychol Soc. 1997;3:269–75.

    PubMed  CAS  Google Scholar 

  32. Morrow LA, Steinhauer SR, Condray R. Differential associations of P300 amplitude and latency with cognitive and psychiatric function in solvent-exposed adults. J Neuropsychiatry Clin Neurosci. 1996;8:446–9.

    PubMed  CAS  Google Scholar 

  33. Morrow LA, Steinhauer SR, Condray R. Predictors of improvement in P300 latency in solvent-exposed adults. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11:146–50.

    PubMed  CAS  Google Scholar 

  34. Utti RJ, Snow BJ, Shinotoh H, Vingerhoets JG, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB. Parkinsonism induced by solvent abuse. Ann Neurol. 1994;35:616–9.

    Google Scholar 

  35. Brett A. Myeloneuropathy from whipped cream bulbs presenting as conversion disorder. Aust NZ J Psychiatry. 1997;31:131–2.

    CAS  Google Scholar 

  36. Weintraub E, Gandhi D, Robinson C. Medical complications due to mothball abuse. South Med J. 2000;93:427–9.

    PubMed  CAS  Google Scholar 

  37. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J. 1996;89:455–62.

    PubMed  CAS  Google Scholar 

  38. Joe GW, Garriott JC, Simpson DD. Physical symptoms and psychological distress among inhalant users. Hisp J Behav Sci. 1991;13:297–314.

    Google Scholar 

  39. Matsuoka M. Neurotoxicity of organic solvents—recent findings. Brain Nerve. 2007;59:591–6.

    PubMed  CAS  Google Scholar 

  40. Gautschi OP, Cadosch D, Zellweger R. Postural tremor induced by paint sniffing. Neurol India. 2007;55:393–5.

    PubMed  Google Scholar 

  41. Valpey R, Sumi SM, Copass MK, Goble GJ. Acute and chronic progressive encephalopathy due to gasoline sniffing. Neurology. 1978;28:507–10.

    PubMed  CAS  Google Scholar 

  42. Finch CK, Lobo BL. Acute inhalant-related neurotoxicity with delayed recovery. Ann Pharmacother. 2005;39:169–72.

    PubMed  Google Scholar 

  43. Stolley BT. Long-term cognitive sequelae of solvent intoxication. Neurotoxicol Teratol. 1996;18:471–6.

    Google Scholar 

  44. Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain. 1998;121:1903–17.

    PubMed  Google Scholar 

  45. Tenbein M, Pillay N. Sensory evoked potential in inhalant ­(volatile solvent) abuse. J Paediatr Child Health. 1993;29:206–8.

    Google Scholar 

  46. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology. 1986;36:698–702.

    PubMed  CAS  Google Scholar 

  47. Korman M, Trimboli F, Semler I. A comparative evaluation of 162 inhalant users. Addict Behav. 1980;5:143–52.

    PubMed  CAS  Google Scholar 

  48. Yamanouchi N, Okada S, Kodama K, Hirai S, Sekine H, Murakami A, Komatsu N, Sakamoto T, Sato T. White matter changes caused by chronic solvent abuse. Am J Neuroradiol. 1995;16:1643–9.

    PubMed  CAS  Google Scholar 

  49. Yamanouchi N, Okada S, Kodama K, Sakamoto T, Sekine H, Hirai S, Murakami A, Komatsu N, Sato T. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand. 1997;96:34–9.

    PubMed  CAS  Google Scholar 

  50. Kucuk NO, Kilic EO, Aysev A, Gencoglu EA, Aras G, Soylu A, Erbay G. Brain SPECT finding in long-term inhalant abuse. Nucl Med Commun. 2000;21:769–73.

    PubMed  CAS  Google Scholar 

  51. Okada S, Yamanouchi N, Kodama K, Uchida Y, Hirai S, Sakamoto T, Noda S, Komatsu N, Sato T. Regional cerebral blood flow abnormalities in chronic solvent abusers. Psychiatry Clin Neurosci. 2000;53:351–6.

    Google Scholar 

  52. Yamanouchi N, Okada S, Kodama K, Sato T. Central nervous ­system impairment caused by chronic solvent abuse—a review of Japanese studies on the clinical and neuroimaging aspects. Addict Biol. 1998;3:15–27.

    Google Scholar 

  53. Tenebein M. Neonatal abstinence syndrome due to maternal inhalant abuse. Clin Res. 1993;41:298.

    PubMed  CAS  Google Scholar 

  54. Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed. 1996;74:F204–7.

    PubMed  CAS  Google Scholar 

  55. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003;68:869–74.

    PubMed  Google Scholar 

  56. Kong JT, Schmiesing C. Concealed mothball abuse prior to anesthesia: mothballs, inhalants, and their management. Acta Anaesthesiol Scand. 2005;49:113–6.

    PubMed  Google Scholar 

  57. Shepard RT. Mechanism of sudden death associate with volatile substance abuse. Hum Toxicol. 1989;8:287–92.

    Google Scholar 

  58. Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile solvent abuse. Hum Toxicol. 1989;8:301–6.

    PubMed  CAS  Google Scholar 

  59. Atay AA, Kismet E, Turkbay T, Kocaoglu M, Demirkaya E, Sarici SU, Congologlu A, Gokcay E. Bone mass toxicity associated with inhalation exposure to toluene. Bio Trace Elem Res. 2005;105:197–203.

    CAS  Google Scholar 

  60. Dundaroz MR, Turkbay T, Sarici SU, Akay C, Sayal A, Denli M. Selenium and zinc levels in volatile solvent abusers. Bio Trace Elem Res. 2002;88:119–23.

    CAS  Google Scholar 

  61. Guo GL, Rose D, Barnett JB, Soderberg LS. Acute exposure to the abused inhalant, isobutyl nitrite, reduced T cell responsiveness and spleen cellularity. Toxicol Lett. 2000;116:151–8.

    PubMed  CAS  Google Scholar 

  62. O’Brien ET, Yeoman WB, Hobby JAE. Hepatorenal damage from toluene in a “glue sniffer”. Br Med J. 1971;2:29–30.

    PubMed  Google Scholar 

  63. Wiseman MN, Banim S. Glue-sniffers’ heart? Br Med J. 1987;294:739.

    CAS  Google Scholar 

  64. Lorenc JD. Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr. 2003;15:204–9.

    PubMed  Google Scholar 

  65. Dukanovic B. Consequences of abuse of inhalants. Med Arh. 1992;46:91–3.

    PubMed  CAS  Google Scholar 

  66. Archibald CP, Schechter MT, Le TN, Craib KJ, Montaner JS, O’Shaughnessy MV. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi’s sarcoma in a cohort of homosexual men. Epidemiology. 1992;3:203–9.

    PubMed  CAS  Google Scholar 

  67. Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J. Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epdiemiol. 1987;125:1035–47.

    CAS  Google Scholar 

  68. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343:1369–77.

    PubMed  CAS  Google Scholar 

  69. Soderberg LS, Ponnappan U, Roy A, Schafer R, Barnett JB. Production of macrophage IL-1Β was inhibited both at the levels of transcription and maturation by caspase-1 following inhalation exposure to isobutyl nitrite. Toxicol Lett. 2004;152:47–56.

    PubMed  CAS  Google Scholar 

  70. Soderberg LSF. T-cell functions are impaired by inhaled isobutyl nitrite through a T-independent mechanism. Toxicol Lett. 1994;70:319–29.

    PubMed  CAS  Google Scholar 

  71. Soderberg LSF. Increased tumor growth in mice exposed to inhaled isobutyl nitrite. Toxicol Lett. 1999;104:35–41.

    PubMed  CAS  Google Scholar 

  72. Ridenour TA, Bray BC, Cottler LB. Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. Drug Alcohol Depend. 2007;91:40–9.

    PubMed  CAS  Google Scholar 

  73. Hansen WB, McNeal RB. Self-initiated cessation from substance use: a longitudinal study of the relationship between postulated mediators and quitting. J Drug Issues. 2001;31:957–75.

    Google Scholar 

  74. Smitham DM. Understanding inhalant abuse: an application of ­primary socialization theory. Diss Abstr Int. 2001;61:4430.

    Google Scholar 

  75. Morrow LA, Gibson C, Bagovich GR, Stein L, Condray R, Scott A. Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Psychosom Med. 2000;62:746–50.

    PubMed  CAS  Google Scholar 

  76. Condray R, Morrow LA, Steinhauer SR, Hodgson M, Kelley M. Mood and behavioral symptoms in individuals with chronic ­solvent exposure. Psychiatry Res. 2000;97:191–206.

    PubMed  CAS  Google Scholar 

  77. Oetting ER, Edwards RW, Beauvais F. Social and psychological factors underlying inhalant abuse. In: Crider RA, Rouse CD, ­editors. Epidemiology of inhalant abuse: an update (NIDA Monograph No. 85, pp.172-203). Rockville, MD: U.S. Public Health Service; 1988.

    Google Scholar 

  78. Walker DD, Venner K, Hill DE, Meyers RJ, Miller WR. A comparison of alcohol and drug disorders: Is there evidence for a developmental sequence of drug abuse? Addict Behav. 2004;29:817–23.

    PubMed  Google Scholar 

  79. Warner LA. Predictors of substance use, problems and dependence: results from the National Comorbidity Survey. Diss Abst Int. 1999;59:2722.

    Google Scholar 

  80. Matsumoto T, Kosaka K, Miyakawa T, Kamijo A, Endo K, Yabana T, Kishimoto H, Okudaira K. Clinical features of cigarette lighter fluid (butane gas) abusers. Clin Psychiatry. 2001;43:875–83.

    Google Scholar 

  81. Bennett ME, Walters ST, Miller JH, Woodall WG. Relationship of early inhalant use to substance use in college students. J Subst Abuse. 2000;12:227–40.

    PubMed  CAS  Google Scholar 

  82. Ramirez JR, Crano WD, Quist R. Acculturation, familism, parental monitoring, and knowledge as predictors of marijuana and inhalant use in adolescents. Psychol Addict Behav. 2004;18:3–11.

    PubMed  Google Scholar 

  83. Mosher C, Rotolo T, Phillips D, Krupski A, Stark K. Minority ­adolescents and substance use risk/protective factors: a focus on inhalant use. Adolescence. 2004;39:489–502.

    PubMed  Google Scholar 

  84. Bonnheim ML, Korman M. Family interaction and acculturation in Mexican-American inhalant users. J Psychoactive Drugs. 1985;17:25–33.

    PubMed  CAS  Google Scholar 

  85. Simpson DD, Joe GE, Barrett ME. Inhalant use by Mexican American youth: an introduction. Hisp J Behav Sci. 1991;13:246–55.

    Google Scholar 

  86. Howard MO, Jenson JM. Inhalant use among antisocial youth: prevalence and correlates. Addict Behav. 1999;41:59–74.

    Google Scholar 

  87. Wu T, Howard MO. Substance use disorders among inhalant users: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Addict Behav. 2008;33:968–73.

    PubMed  Google Scholar 

  88. Wu LT, Howard MO. Psychiatric disorders among inhalant users: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;88:146–55.

    PubMed  Google Scholar 

  89. Freedenthal S, Vaughn MG, Jenson JM, Howard MO. Inhalant use and suicidality among incarcerated youth. Drug Alcohol Depend. 2007;90:129–33.

    Google Scholar 

  90. Jacobs AM, Ghodse AH. Delinquency and regular solvent abuse: an unfavorable combination? Br J Addict. 1988;83:965–8.

    PubMed  CAS  Google Scholar 

  91. McGarvey EL, Canterbury RJ, Waite D. Delinquency and family problems in incarcerated adolescents with and without a history of inhalant use. Addict Behav. 1996;21:537–42.

    PubMed  CAS  Google Scholar 

  92. Compton WM, Cottler LB, Dinwiddie SH, Spitznagel EL, Mager DE, Asmus G. Inhalant use: characteristics and predictors. Am J Addict. 1994;3:263–72.

    Google Scholar 

  93. Bates SC, Plemons BW, Jumper-Thurman P, Beauvais F. Volatile solvent abuse: patterns by gender and ethnicity among school attenders and dropouts. Drugs Soc. 1997;10:61–78.

    Google Scholar 

  94. Liu LY. Substance use among youths at high risk of dropping out: grades 7-12 in Texas, 1998. Texas Commission on Alcohol and Drug Abuse; 1998.

    Google Scholar 

  95. Wada K, Greberman SB, Konuma K, Hirai S. HIV and HCV infection among drug users in Japan. Addiction. 1999;94:1063–70.

    PubMed  CAS  Google Scholar 

  96. Dinwiddie SH. Abuse of inhalants: a review. Addiction. 1994;89:925–39.

    PubMed  CAS  Google Scholar 

  97. Barnes GE. Solvent abuse: a review. Int J Addict. 1979;14:1–26.

    PubMed  CAS  Google Scholar 

  98. Dinwiddie SH. Psychological and psychiatric consequences of inhalants. In: Tarter R, editor. Handbook of substance abuse: neurobehavioral pharmacology. New York: Plenum; 1998.

    Google Scholar 

  99. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharm. 1994;2:244–68.

    Google Scholar 

  100. Howard MO, Cottler LB, Compton WM, Ben-Abdallah A. Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders. Drug Alcohol Depend. 2001;61:223–8.

    PubMed  CAS  Google Scholar 

  101. Wiley JL, Bale AS, Balster RL. Evaluation of toluene dependence and cross-sensitization to diazepam. Life Sci. 2003;72:3023–33.

    PubMed  CAS  Google Scholar 

  102. Blokhina EA, Dravolina OA, Bespalov AY, Balster RL, Zvartau EE. Intravenous self-administration of abused solvents and anesthetics in mice. Eur J Pharmacol. 2004;485:211–8.

    PubMed  CAS  Google Scholar 

  103. Gerasimov MR, Collier L, Ferrieri A, Alexoff D, Lee D, Gifford AN, Balster RL. Toluene inhalation produces a conditioned place preference in rats. Eur J Pharmacol. 2003;477:45–52.

    PubMed  CAS  Google Scholar 

  104. Howard MO, Cottler LB, Compton WM, Abdallah A. Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders. Drug Alcohol Depend. 2001;61:223–8.

    PubMed  CAS  Google Scholar 

  105. Balster RL. Inhalant abuse, a forgotten drug abuse problem. Proceedings of the College on Problems of Drug Dependence; 1996.

    Google Scholar 

  106. Committee on Substance Abuse and Committee on Native American Child Health. Am Acad Pediatr. Pediatrics. 1996;97:420–3.

    Google Scholar 

  107. Smart RG. Inhalant abuse in Canada. Subst Use Misuse. 1997;32:1835–40.

    Google Scholar 

  108. Wingert JL, Fifield MG. Characteristics of Native American users of inhalants. Int J Addict. 1985;20:1575–82.

    PubMed  CAS  Google Scholar 

  109. Burns CB, D’abbs P, Currie BJ. Patterns of petrol sniffing and other drug use in young men from an Australian Aboriginal community in Arnhem Land, Northern Territory. Drug Alcohol Rev. 1995;14:159–69.

    PubMed  CAS  Google Scholar 

  110. Beauvais F, Oetting ER, Edwards RW. Trends in drug use of Indian adolescents living on reservations: 1975–1983. Am J Drug Alcohol Abuse. 1985;11:209–29.

    PubMed  CAS  Google Scholar 

  111. Wittig MCW, Wright JD, Kaminsky DC. Substance use among street children in Honduras. Subst Use Misuse. 1997;32:805–27.

    PubMed  CAS  Google Scholar 

  112. Smart RG. Inhalant use and abuse in Canada. In: Crider RA, Rouse BA, editors. Epidemiology of inhalant abuse: an update. NIDA Research Monograph 85, Rockville, MD; 1988.

    Google Scholar 

  113. Bachrach KM, Sandler IN. A retrospective assessment of inhalant use in the Barrio: implications for prevention. Int J Addict. 1985;20:1177–89.

    PubMed  CAS  Google Scholar 

  114. Misa LK, Kofoed L, Fuller W. Treatment of inhalant abuse with risperidone. J Clin Psychiatry. 1999;60:620.

    Google Scholar 

  115. Lowenstein LF. Glue sniffing: background features and treatment by aversion methods and group therapy. Practitioner. 1982;226:1113–6.

    PubMed  CAS  Google Scholar 

  116. Marsolek MR, White NC, Litowitz TL. Inhalant abuse: monitoring trends by using poison control data, 1993-2008. Pediatrics. 2010;125:906–13.

    PubMed  Google Scholar 

  117. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey on Drug Use, 1975–2006. Vol I: Secondary Students. (NIH Pub. No. 07-6205); 2007.

    Google Scholar 

  118. Substance Abuse and Mental Health Administration, Office of Applied Studies. Inhalant use across the adolescent years. National Survey on Drug Use and Health, The NSDUH Report, March 13; 2008.

    Google Scholar 

  119. Siqueira LM, Crandall LA. Inhalant use in Florida youth. Subst Abuse. 2006;27:27–35.

    Google Scholar 

  120. Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry. 2004;43:1206–14.

    PubMed  Google Scholar 

  121. Wu LT, Ringwalt CL. Inhalant use and disorders among adults in the United States. Drug Alcohol Depend. 2006;85:1–11.

    PubMed  CAS  Google Scholar 

  122. Crocetti M. Inhalants. Pediatr Rev. 2008;29:33–4.

    PubMed  Google Scholar 

  123. D’Abbs P, MacLean S. Volatile substance misuse: a review of interventions. Australian Department of Health and Aging, National Drug Strategy, Monograph Series No. 65; 2008.

    Google Scholar 

  124. Wu LT, Howard MO. Psychiatric disorders in inhalant users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;88:146–55.

    PubMed  Google Scholar 

  125. Wu L, Howard MO. Is inhalant use a risk factor for heroin and injection drug use among adolescents in the general population? Addict Behav. 2007;32:265–81.

    PubMed  Google Scholar 

  126. Storr CL, Westergaard R, Anthony JC. Early onset inhalant use and risk for opiate addiction by young adulthood. Drug Alcohol Depend. 2005;78:253–61.

    PubMed  Google Scholar 

  127. SAMHSA, Office of Applied Studies. Inhalant use and delinquent behaviors among young adolescents. National Survey on Drug Use and Health, NSDUH Report, March 17; 2007.

    Google Scholar 

  128. Williams JF, Storck M, Committee on Substance Abuse and Committee on Native American Child Youth. Inhalant abuse. Pediatrics. 2007;119:1009–17.

    PubMed  Google Scholar 

  129. Perron BE, Howard MO. Perceived risk of harm and intentions of future inhalant use among adolescent inhalant users. Drug Alcohol Depend. 2008;97:185–9.

    PubMed  Google Scholar 

  130. Caldwell LL, Ridenour TA, Smith EA, Maldonado-Molina M. Results from a three-year efficacy trial on the effects of a leisure-based intervention on substance use. (Under review).

    Google Scholar 

  131. Furr-Holden CDM, Ialongo NS, Anthony JC, Petras H, Kellam SG. Developmentally inspired drug prevention: middle school outcomes in a school-based randomized prevention trial. Drug Alcohol Depend. 2004;73:149–58.

    PubMed  Google Scholar 

  132. Boylan J, Braye S, Worley C. Life’s a gas? The training needs of practitioners and careers working with young people misusing volatile substances. Soc Work Educ. 2006;25:591–607.

    Google Scholar 

  133. Cottler LB, Robins LN, Helzer JE. The reliability of the CIDI-SAM: A comprehensive substance abuse interview. Br J Addict. 1989;84:801–14.

    PubMed  CAS  Google Scholar 

  134. World Health Organization. Schedules for clinical assessment in neuropsychiatry. American Psychiatric Press, Washington, DC; 1993.

    Google Scholar 

  135. Wasfi IA, Al-Awadhi AH, Al-Hatali ZN, Al-Rayami FJ, Al Katheeri NA. Rapid and sensitive static headspace gas ­chromatography-mass spectrometry method for the analysis of ethanol and abused inhalants in blood. J Chromatogr B. 2004;799:331–6.

    Google Scholar 

  136. Broussard LA, Broussard A, Pittman T, Lafferty D, Presley L. Headspace gas chromatographic method for the measurement of difluoroethane in blood. Clin Lab Sci. 2001;14:3–5.

    PubMed  CAS  Google Scholar 

  137. Broussard LA. The role of the laboratory in detecting inhalant abuse. Clin Lab Sci. 2000;13:205–9.

    PubMed  CAS  Google Scholar 

  138. Ramirez JR, Crano WD, Quist R, Burgoon M, Alvaro EM, Grandpre J. Acculturation, familism, parental monitoring, and knowledge as predictors of marijuana and inhalant use in ­adolescents. Psychol Addict Behav. 2004;18:3–11.

    PubMed  Google Scholar 

  139. Spiller HA, Krenzelok EP. Epidemiology of inhalant abuse reported to two regional poison centers. J Toxicol Clin Toxicol. 1997;35:167–73.

    PubMed  CAS  Google Scholar 

  140. Beasley M, Frampton L, Fountain J. Inhalant abuse in New Zealand. NZ Med J. 2006;119:1233.

    Google Scholar 

  141. Dell CA, Dell DE, Hopkins C. Resilience and holistic inhalant abuse treatment. J Aborig Health. 2005;2:4–12.

    Google Scholar 

  142. McGarvey EL, Canterbury RJ, Waite D. Delinquency and family problems in incarcerated adolescents with and without a history of inhalant use. Addict Behav. 1996;21:537–42.

    PubMed  CAS  Google Scholar 

  143. McGarvey EL, Clavet GJ, Mason W, Waite D. Adolescent ­inhalant abuse: environments of use. Am J Drug Alcohol Abuse. 1999;25:731–41.

    PubMed  CAS  Google Scholar 

  144. Reed BJ, May PA. Inhalant abuse and juvenile delinquency: a ­control study in Albuquerque, New Mexico. Int J Addict. 1984;19:789–803.

    PubMed  CAS  Google Scholar 

  145. Howard MO, Jenson JM. Inhalant use among antisocial youth: prevalence and correlates. Addict Behav. 1999;24:59–74.

    PubMed  CAS  Google Scholar 

  146. Sakai JT, Hall SK, Mikulich-Gilbertson SK, Crowley TJ. Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry. 2004;43:1080–8.

    PubMed  Google Scholar 

Download references

Acknowledgement

Funding for this research was provided by grants from the National Institute on Drug Abuse (R01 15984, P50 10075).

Author information

Authors and Affiliations

  1. Center for Education and Drug Abuse Research, University of Pittsburgh, 3520 Forbes Ave., Rm 228, Pittsburgh, PA, 15213, USA

    Ty. A. Ridenour Ph.D.

  2. School of Social Work, The University of North Carolina at Chapel Hill, Tate-Turner-Kuralt Building, 3550, Chapel Hill, NC, 27599-3550, USA

    Matthew O. Howard

Authors
  1. Ty. A. Ridenour Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew O. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ty. A. Ridenour Ph.D. .

Editor information

Editors and Affiliations

  1. Inst. Pharmaceutical Sciences, Department of Psychopharmacology, Utrecht University, Universiteitsweg 99, Utrecht, 3584CG, Netherlands

    Joris C. Verster

  2. Dept. Psychiatry, Medical University of South Carolina, President St. 67, Charleston, 29425, South Carolina, USA

    Kathleen Brady

  3. School of Medicine, Div. Alcoholism & Drug Abuse, New York University, First Ave. 550, New York, 10016, New York, USA

    Marc Galanter

  4. Institute of Psychiatry, King's College London, National Addiction Centre, Windsor Walk 4, London, SE5 8AF, United Kingdom

    Patricia Conrod

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ridenour, T.A., Howard, M.O. (2012). Inhalants Abuse: Status of Etiology and Intervention. In: Verster, J., Brady, K., Galanter, M., Conrod, P. (eds) Drug Abuse and Addiction in Medical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3375-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3375-0_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3374-3

  • Online ISBN: 978-1-4614-3375-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation